Mylan Launches Generic Dexedrine(R) Capsules

HERTFORDSHIRE, England and PITTSBURGH, Aug. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Dextroamphetamine Sulfate Extended-release Capsules, 5 mg, 10 mg, and 15 mg, a generic versi... Biopharmaceuticals, Generics, Product Launch Mylan, Dextroamphetamine, Dexedrine, narcolepsy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news